Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry

The real-world outcomes of the use of the BASILICA (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction) transcatheter technique in Europe have not been described. We sought to evaluate the procedural and one-year outcomes of BASILICA in pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EuroIntervention 2023-08, Vol.19 (5), p.e432-e441
Hauptverfasser: Abdel-Wahab, Mohamed, Richter, Ines, Taramasso, Maurizio, Unbehaun, Axel, Rudolph, Tanja, Ribichini, Flavio L, Binder, Ronald, Schofer, Joachim, Mangner, Norman, Dambrink, Jan-Henk, Trejo-Velasco, Blanca, Thiele, Holger, Kitamura, Mitsunobu, Lanz, Jonas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e441
container_issue 5
container_start_page e432
container_title EuroIntervention
container_volume 19
creator Abdel-Wahab, Mohamed
Richter, Ines
Taramasso, Maurizio
Unbehaun, Axel
Rudolph, Tanja
Ribichini, Flavio L
Binder, Ronald
Schofer, Joachim
Mangner, Norman
Dambrink, Jan-Henk
Trejo-Velasco, Blanca
Thiele, Holger
Kitamura, Mitsunobu
Lanz, Jonas
description The real-world outcomes of the use of the BASILICA (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction) transcatheter technique in Europe have not been described. We sought to evaluate the procedural and one-year outcomes of BASILICA in patients at high risk for coronary artery obstruction (CAO) undergoing transcatheter aortic valve implantation (TAVI) in a multicentre European registry (EURO-BASILICA). Seventy-six patients undergoing BASILICA and TAVI at ten European centres were included. Eighty-five leaflets were identified as targets for BASILICA due to high risk for CAO. The updated Valve Academic Research Consortium 3 (VARC-3) definitions were used to determine prespecified endpoints of technical and procedural success and adverse events up to one year. Treated aortic valves included native (5.3%), surgical bioprosthetic (92.1%) and transcatheter valves (2.6%). Double BASILICA (for both left and right coronary cusps) was performed in 11.8% of patients. Technical success with BASILICA was achieved in 97.7% and resulted in freedom from any target leaflet-related CAO in 90.6% with a low rate of complete CAO (2.4%). Target leaflet-related CAO occurred significantly more often in older and stentless bioprosthetic valves and with higher implantation levels of transcatheter heart valves. Procedural success was 88.2%, and freedom from VARC-3-defined early safety endpoints was 79.0%. One-year survival was 84.2%; 90.5% of patients were in New York Heart Association Functional Class I/II. EURO-BASILICA is the first multicentre study evaluating the BASILICA technique in Europe. The technique appeared feasible and effective in preventing TAVI-induced CAO, and one-year clinical outcomes were favourable. The residual risk for CAO requires further study.
doi_str_mv 10.4244/EIJ-D-22-00960
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10397663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37103779</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-b554c3328dd7d85535114086383f666bd72f253200cc5e8b82a678d90be6aa133</originalsourceid><addsrcrecordid>eNpVkF9PwjAUxRujEURffTT9AsX-2drOF4MwFUOCUXluuq6DmW3FbjPh2ztACT7dm3vPOffmB8A1wcOABsFtPH1BE0Qpwjji-AT0ScQjxClhp0d9D1zU9SfGgcREnIMeEwQzIaI-KF69MzZtvS6grlLoKos2Vnvo2sa40tbQZbBZWfgwep_OpuMRbKxZVflXa2Fewbj1bm3vdoqyLZrc2KrxFsaLtzk6WLxd5nXjN5fgLNNFba9-6wAsHuOP8TOazZ863QwZFpIGJWEYGMaoTFORyjDshiTAkjPJMs55kgqa0ZBRjI0JrUwk1VzINMKJ5VoTxgbgfp-7bpPSprufdKHWPi-13yinc_V_U-UrtXTfqqMSCc63CcN9gvGurr3NDmaC1Ra86sCriaJU7cB3hpvjkwf5H2n2A-RxfjA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry</title><source>MEDLINE</source><source>PubMed Central</source><creator>Abdel-Wahab, Mohamed ; Richter, Ines ; Taramasso, Maurizio ; Unbehaun, Axel ; Rudolph, Tanja ; Ribichini, Flavio L ; Binder, Ronald ; Schofer, Joachim ; Mangner, Norman ; Dambrink, Jan-Henk ; Trejo-Velasco, Blanca ; Thiele, Holger ; Kitamura, Mitsunobu ; Lanz, Jonas</creator><creatorcontrib>Abdel-Wahab, Mohamed ; Richter, Ines ; Taramasso, Maurizio ; Unbehaun, Axel ; Rudolph, Tanja ; Ribichini, Flavio L ; Binder, Ronald ; Schofer, Joachim ; Mangner, Norman ; Dambrink, Jan-Henk ; Trejo-Velasco, Blanca ; Thiele, Holger ; Kitamura, Mitsunobu ; Lanz, Jonas</creatorcontrib><description>The real-world outcomes of the use of the BASILICA (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction) transcatheter technique in Europe have not been described. We sought to evaluate the procedural and one-year outcomes of BASILICA in patients at high risk for coronary artery obstruction (CAO) undergoing transcatheter aortic valve implantation (TAVI) in a multicentre European registry (EURO-BASILICA). Seventy-six patients undergoing BASILICA and TAVI at ten European centres were included. Eighty-five leaflets were identified as targets for BASILICA due to high risk for CAO. The updated Valve Academic Research Consortium 3 (VARC-3) definitions were used to determine prespecified endpoints of technical and procedural success and adverse events up to one year. Treated aortic valves included native (5.3%), surgical bioprosthetic (92.1%) and transcatheter valves (2.6%). Double BASILICA (for both left and right coronary cusps) was performed in 11.8% of patients. Technical success with BASILICA was achieved in 97.7% and resulted in freedom from any target leaflet-related CAO in 90.6% with a low rate of complete CAO (2.4%). Target leaflet-related CAO occurred significantly more often in older and stentless bioprosthetic valves and with higher implantation levels of transcatheter heart valves. Procedural success was 88.2%, and freedom from VARC-3-defined early safety endpoints was 79.0%. One-year survival was 84.2%; 90.5% of patients were in New York Heart Association Functional Class I/II. EURO-BASILICA is the first multicentre study evaluating the BASILICA technique in Europe. The technique appeared feasible and effective in preventing TAVI-induced CAO, and one-year clinical outcomes were favourable. The residual risk for CAO requires further study.</description><identifier>ISSN: 1969-6213</identifier><identifier>ISSN: 1774-024X</identifier><identifier>EISSN: 1969-6213</identifier><identifier>DOI: 10.4244/EIJ-D-22-00960</identifier><identifier>PMID: 37103779</identifier><language>eng</language><publisher>France: Europa Edition</publisher><subject>Aged ; Aortic Stenosis ; Aortic Valve - surgery ; Aortic Valve Stenosis - surgery ; Bioprosthesis ; Clinical Research ; Coronary Occlusion ; Coronary Occlusion - surgery ; Heart Valve Prosthesis ; Humans ; Prosthesis Design ; Tavi ; Transcatheter Aortic Valve Replacement - adverse effects ; Treatment Outcome ; Valve-in-Valve</subject><ispartof>EuroIntervention, 2023-08, Vol.19 (5), p.e432-e441</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-b554c3328dd7d85535114086383f666bd72f253200cc5e8b82a678d90be6aa133</citedby><cites>FETCH-LOGICAL-c351t-b554c3328dd7d85535114086383f666bd72f253200cc5e8b82a678d90be6aa133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397663/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397663/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37103779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdel-Wahab, Mohamed</creatorcontrib><creatorcontrib>Richter, Ines</creatorcontrib><creatorcontrib>Taramasso, Maurizio</creatorcontrib><creatorcontrib>Unbehaun, Axel</creatorcontrib><creatorcontrib>Rudolph, Tanja</creatorcontrib><creatorcontrib>Ribichini, Flavio L</creatorcontrib><creatorcontrib>Binder, Ronald</creatorcontrib><creatorcontrib>Schofer, Joachim</creatorcontrib><creatorcontrib>Mangner, Norman</creatorcontrib><creatorcontrib>Dambrink, Jan-Henk</creatorcontrib><creatorcontrib>Trejo-Velasco, Blanca</creatorcontrib><creatorcontrib>Thiele, Holger</creatorcontrib><creatorcontrib>Kitamura, Mitsunobu</creatorcontrib><creatorcontrib>Lanz, Jonas</creatorcontrib><title>Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry</title><title>EuroIntervention</title><addtitle>EuroIntervention</addtitle><description>The real-world outcomes of the use of the BASILICA (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction) transcatheter technique in Europe have not been described. We sought to evaluate the procedural and one-year outcomes of BASILICA in patients at high risk for coronary artery obstruction (CAO) undergoing transcatheter aortic valve implantation (TAVI) in a multicentre European registry (EURO-BASILICA). Seventy-six patients undergoing BASILICA and TAVI at ten European centres were included. Eighty-five leaflets were identified as targets for BASILICA due to high risk for CAO. The updated Valve Academic Research Consortium 3 (VARC-3) definitions were used to determine prespecified endpoints of technical and procedural success and adverse events up to one year. Treated aortic valves included native (5.3%), surgical bioprosthetic (92.1%) and transcatheter valves (2.6%). Double BASILICA (for both left and right coronary cusps) was performed in 11.8% of patients. Technical success with BASILICA was achieved in 97.7% and resulted in freedom from any target leaflet-related CAO in 90.6% with a low rate of complete CAO (2.4%). Target leaflet-related CAO occurred significantly more often in older and stentless bioprosthetic valves and with higher implantation levels of transcatheter heart valves. Procedural success was 88.2%, and freedom from VARC-3-defined early safety endpoints was 79.0%. One-year survival was 84.2%; 90.5% of patients were in New York Heart Association Functional Class I/II. EURO-BASILICA is the first multicentre study evaluating the BASILICA technique in Europe. The technique appeared feasible and effective in preventing TAVI-induced CAO, and one-year clinical outcomes were favourable. The residual risk for CAO requires further study.</description><subject>Aged</subject><subject>Aortic Stenosis</subject><subject>Aortic Valve - surgery</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Bioprosthesis</subject><subject>Clinical Research</subject><subject>Coronary Occlusion</subject><subject>Coronary Occlusion - surgery</subject><subject>Heart Valve Prosthesis</subject><subject>Humans</subject><subject>Prosthesis Design</subject><subject>Tavi</subject><subject>Transcatheter Aortic Valve Replacement - adverse effects</subject><subject>Treatment Outcome</subject><subject>Valve-in-Valve</subject><issn>1969-6213</issn><issn>1774-024X</issn><issn>1969-6213</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkF9PwjAUxRujEURffTT9AsX-2drOF4MwFUOCUXluuq6DmW3FbjPh2ztACT7dm3vPOffmB8A1wcOABsFtPH1BE0Qpwjji-AT0ScQjxClhp0d9D1zU9SfGgcREnIMeEwQzIaI-KF69MzZtvS6grlLoKos2Vnvo2sa40tbQZbBZWfgwep_OpuMRbKxZVflXa2Fewbj1bm3vdoqyLZrc2KrxFsaLtzk6WLxd5nXjN5fgLNNFba9-6wAsHuOP8TOazZ863QwZFpIGJWEYGMaoTFORyjDshiTAkjPJMs55kgqa0ZBRjI0JrUwk1VzINMKJ5VoTxgbgfp-7bpPSprufdKHWPi-13yinc_V_U-UrtXTfqqMSCc63CcN9gvGurr3NDmaC1Ra86sCriaJU7cB3hpvjkwf5H2n2A-RxfjA</recordid><startdate>20230807</startdate><enddate>20230807</enddate><creator>Abdel-Wahab, Mohamed</creator><creator>Richter, Ines</creator><creator>Taramasso, Maurizio</creator><creator>Unbehaun, Axel</creator><creator>Rudolph, Tanja</creator><creator>Ribichini, Flavio L</creator><creator>Binder, Ronald</creator><creator>Schofer, Joachim</creator><creator>Mangner, Norman</creator><creator>Dambrink, Jan-Henk</creator><creator>Trejo-Velasco, Blanca</creator><creator>Thiele, Holger</creator><creator>Kitamura, Mitsunobu</creator><creator>Lanz, Jonas</creator><general>Europa Edition</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20230807</creationdate><title>Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry</title><author>Abdel-Wahab, Mohamed ; Richter, Ines ; Taramasso, Maurizio ; Unbehaun, Axel ; Rudolph, Tanja ; Ribichini, Flavio L ; Binder, Ronald ; Schofer, Joachim ; Mangner, Norman ; Dambrink, Jan-Henk ; Trejo-Velasco, Blanca ; Thiele, Holger ; Kitamura, Mitsunobu ; Lanz, Jonas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-b554c3328dd7d85535114086383f666bd72f253200cc5e8b82a678d90be6aa133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aged</topic><topic>Aortic Stenosis</topic><topic>Aortic Valve - surgery</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Bioprosthesis</topic><topic>Clinical Research</topic><topic>Coronary Occlusion</topic><topic>Coronary Occlusion - surgery</topic><topic>Heart Valve Prosthesis</topic><topic>Humans</topic><topic>Prosthesis Design</topic><topic>Tavi</topic><topic>Transcatheter Aortic Valve Replacement - adverse effects</topic><topic>Treatment Outcome</topic><topic>Valve-in-Valve</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdel-Wahab, Mohamed</creatorcontrib><creatorcontrib>Richter, Ines</creatorcontrib><creatorcontrib>Taramasso, Maurizio</creatorcontrib><creatorcontrib>Unbehaun, Axel</creatorcontrib><creatorcontrib>Rudolph, Tanja</creatorcontrib><creatorcontrib>Ribichini, Flavio L</creatorcontrib><creatorcontrib>Binder, Ronald</creatorcontrib><creatorcontrib>Schofer, Joachim</creatorcontrib><creatorcontrib>Mangner, Norman</creatorcontrib><creatorcontrib>Dambrink, Jan-Henk</creatorcontrib><creatorcontrib>Trejo-Velasco, Blanca</creatorcontrib><creatorcontrib>Thiele, Holger</creatorcontrib><creatorcontrib>Kitamura, Mitsunobu</creatorcontrib><creatorcontrib>Lanz, Jonas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EuroIntervention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdel-Wahab, Mohamed</au><au>Richter, Ines</au><au>Taramasso, Maurizio</au><au>Unbehaun, Axel</au><au>Rudolph, Tanja</au><au>Ribichini, Flavio L</au><au>Binder, Ronald</au><au>Schofer, Joachim</au><au>Mangner, Norman</au><au>Dambrink, Jan-Henk</au><au>Trejo-Velasco, Blanca</au><au>Thiele, Holger</au><au>Kitamura, Mitsunobu</au><au>Lanz, Jonas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry</atitle><jtitle>EuroIntervention</jtitle><addtitle>EuroIntervention</addtitle><date>2023-08-07</date><risdate>2023</risdate><volume>19</volume><issue>5</issue><spage>e432</spage><epage>e441</epage><pages>e432-e441</pages><issn>1969-6213</issn><issn>1774-024X</issn><eissn>1969-6213</eissn><abstract>The real-world outcomes of the use of the BASILICA (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction) transcatheter technique in Europe have not been described. We sought to evaluate the procedural and one-year outcomes of BASILICA in patients at high risk for coronary artery obstruction (CAO) undergoing transcatheter aortic valve implantation (TAVI) in a multicentre European registry (EURO-BASILICA). Seventy-six patients undergoing BASILICA and TAVI at ten European centres were included. Eighty-five leaflets were identified as targets for BASILICA due to high risk for CAO. The updated Valve Academic Research Consortium 3 (VARC-3) definitions were used to determine prespecified endpoints of technical and procedural success and adverse events up to one year. Treated aortic valves included native (5.3%), surgical bioprosthetic (92.1%) and transcatheter valves (2.6%). Double BASILICA (for both left and right coronary cusps) was performed in 11.8% of patients. Technical success with BASILICA was achieved in 97.7% and resulted in freedom from any target leaflet-related CAO in 90.6% with a low rate of complete CAO (2.4%). Target leaflet-related CAO occurred significantly more often in older and stentless bioprosthetic valves and with higher implantation levels of transcatheter heart valves. Procedural success was 88.2%, and freedom from VARC-3-defined early safety endpoints was 79.0%. One-year survival was 84.2%; 90.5% of patients were in New York Heart Association Functional Class I/II. EURO-BASILICA is the first multicentre study evaluating the BASILICA technique in Europe. The technique appeared feasible and effective in preventing TAVI-induced CAO, and one-year clinical outcomes were favourable. The residual risk for CAO requires further study.</abstract><cop>France</cop><pub>Europa Edition</pub><pmid>37103779</pmid><doi>10.4244/EIJ-D-22-00960</doi></addata></record>
fulltext fulltext
identifier ISSN: 1969-6213
ispartof EuroIntervention, 2023-08, Vol.19 (5), p.e432-e441
issn 1969-6213
1774-024X
1969-6213
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10397663
source MEDLINE; PubMed Central
subjects Aged
Aortic Stenosis
Aortic Valve - surgery
Aortic Valve Stenosis - surgery
Bioprosthesis
Clinical Research
Coronary Occlusion
Coronary Occlusion - surgery
Heart Valve Prosthesis
Humans
Prosthesis Design
Tavi
Transcatheter Aortic Valve Replacement - adverse effects
Treatment Outcome
Valve-in-Valve
title Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A22%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Procedural%20and%20one-year%20outcomes%20of%20the%20BASILICA%20technique%20in%20Europe:%20the%20multicentre%20EURO-BASILICA%20registry&rft.jtitle=EuroIntervention&rft.au=Abdel-Wahab,%20Mohamed&rft.date=2023-08-07&rft.volume=19&rft.issue=5&rft.spage=e432&rft.epage=e441&rft.pages=e432-e441&rft.issn=1969-6213&rft.eissn=1969-6213&rft_id=info:doi/10.4244/EIJ-D-22-00960&rft_dat=%3Cpubmed_cross%3E37103779%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37103779&rfr_iscdi=true